Extended Data Fig. 10: Cell entry pathway usage by SARS-CoV-2 mutants in nasal epithelium.
From: Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic
a,b, Sensitivity of the SARS-CoV-2 spike mutants to 10 µM each of Camostat and E64d in AAT cells. The dashed line represents the relative virus titre of DMSO-treated condition set as 1.0. Data are represented as mean ± standard error to the mean (SEM) of three or four independent experiments each performed in triplicate. Statistical significance between DMSO- and inhibitor-treated data was determined by one-sample t-test. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001.
